----
Current ValuationThe current P/E ratio is 7.62, within the reasonable range, cheaper than 76.92% of the time in the past 1 years, and the industry ranks 4/23, the industry Median 15.12.
7.62xP/E
$200.15Stock price
$26.27Earnings per share
7.62xP/E
Stock price$200.15Earnings per share$26.27
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 9.22x
- Typical range
- 7.49x–10.52x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 15.12x
06121824
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 15.12x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
THCUSTenet Healthcare | 7.59x | 134.80% | $22.00B |
UHSUSUniversal Health Service-B | 7.10x | 4.45% | $10.38B |
NUTXUSNutex Health | 7.62x | 161.13% | $1.37B |
CYHUSCommunity Health | 9.40x | 128.65% | $338.23M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
